Clinical Trial Update: Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a pediatric therapy in relapsed or refractory precursor B-cell acute lymphoblastic leukemia and lymphoma; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-lymphoblastic Lymphoma
• Precursor B-cell Acute Lymphoblastic Leukemia

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2022-09-28